Table 2 Participant characteristics, baseline: Multi-Ethnic Study of Atherosclerosis, 2000 to 2002
| Â | All participant | HCVD | No HCVD | P. value* |
|---|---|---|---|---|
N total | 6779 | 370 | 6409 | |
N (%) | Â | Â | Â | Â |
Age | 62.2 ± 10.2 | 68.0 ± 9.7 | 61.8 ± 10.2 | < 0.001 |
Gender | Â | Â | Â | Â |
Male | 3197(47.2) | 220(59.5) | 2977(46.5) | < 0.001 |
Female | 3582(52.8) | 150(40.5) | 3432(53.5) | Â |
Education | Â | Â | Â | Â |
Less than diploma | 1215(17.0) | 85(23.0) | 1130(17.7) | < 0.001 |
Diploma or some college | 2814(41.6) | 169(45.8) | 2645(41.4) | Â |
College degree or higher | 2729(40.4) | 115(31.2) | 2614(40.9) | Â |
Race | Â | Â | Â | Â |
Caucasian -Americans | 2614(38.6) | 156(42.2) | 2458(38.3) | 0.003 |
Chinese -Americans | 801(11.8) | 22(5.9) | 779(12.2) | Â |
African -American | 1879(27.7) | 102(27.6) | 1777(27.7) | Â |
Hispanic -Americans | 1485(22.9) | 90(24.3) | 1395(21.8) | Â |
Alcohol status | Â | Â | Â | Â |
Never | 1382(20.5) | 74(20.1) | 1308(20.6) | 0.004 |
Former | 1609(23.9) | 114(31.0) | 1495(23.5) | Â |
Current | 3739(55.6) | 180(48.9) | 3559(55.9) | Â |
Smoking status | Â | Â | Â | Â |
Never | 3400(50.3) | 172(46.6) | 3228(50.5) | 0.003 |
Former | 2475(36.6) | 127(34.4) | 2348(36.7) | Â |
Current | 884(13.1) | 70(19.0) | 814(12.8) | Â |
Diabetes | Â | Â | Â | Â |
Normal | 4972(73.6) | 226(61.3) | 4746(74.3) | < 0.001 |
Impaired fasting glucose | 933(13.8) | 54(14.6) | 879(13.8) | Â |
Untreated diabetes mellitus | 179(2.6) | 10(2.7) | 169(2.6) | Â |
Treated diabetes mellitus | 671(10.0) | 79(21.4) | 5928(9.3) | Â |
Current aspirin use(at least 3 days/wk) | Â | Â | Â | Â |
No | 5202(80.0) | 270(76.5) | 4932(80.3) | 0.07 |
Yes | 1201(20.0) | 83(23.5) | 1208(19.7) | Â |
Hypertension medication use | Â | Â | Â | Â |
No | 4250(62.7) | 175(47.4) | 4075(63.60) | < 0.001 |
Yes | 2526(37.3) | 194(52.6) | 2332(36.4) | Â |
Family history of heart attack | Â | Â | Â | Â |
No | 3639(57.3) | 162(47.2) | 3477(57.8) | < 0.001 |
Yes | 2722(42.8) | 181(52.8) | 2541(42.2) | Â |
Mean(SD) | Â | Â | Â | Â |
Age, y | 62.2(10.2) | 68.0(9.7) | 61.8(10.2) | < 0.001 |
Height, cm | 166.4(10.0) | 166.6(10.4) | 166.3(9.9) | 0.32 |
Total intentional exercise (MET-min/wk) | 1556.2(2344.0) | 1260.7(1808.8) | 1573.2(2370.2) | 0.006 |
LDL-C, mg/dl | 117.2(31.5) | 118.7(31.7) | 117.1(31.5) | 0.34 |
HDL-C, mg/dl | 51.0(14.8) | 47.4(13.7) | 51.2(14.9) | < 0.001 |
Systolic blood pressure, mmHg | 126.6(21.5) | 137.8(23.0) | 125.9(21.2) | < 0.001 |
Triglycerides, mg/dl | 131.5(88.8) | 143.6(81.4) | 130.8(89.2) | < 0.001 |
BMI,Kg/m2 | 28.3(5.4) | 28.6(5.1) | 28.3(5.4) | 0.17 |
 C-Reactive Protein, mg/L | 3.8(5.8) | 4.3(6.0) | 3.7(5.8) | 0.03 |
Fibrinogen, mg/dL | 346.7(73.9) | 369.4(82.5) | 345.4(73.2) | < 0.001 |
Interleukine-6 | 1.6(1.2) | 1.9(1.4) | 1.5(1.2) | < 0.001 |
Psychosocial factor | Â | Â | Â | Â |
CES-D (Range,0–60) | 7.6(7.6) | 8.1(8.1) | 7.5(7.5) | 0.06 |
CBS (Range,0–5) | 1.2(1.2) | 1.3(1.2) | 1.2(1.2) | 0.15 |
ESS (Range,6–30) | 24.1(5.2) | 23.8(5.5) | 24.2(5.3) | 0.36 |
Anxiety (Range,10–40) | 15.9(4.5) | 15.8(4.6) | 15.9(4.5) | 0.62 |